Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALICE QUEEN LIMITED Proxy Solicitation & Information Statement 2022

May 25, 2022

64409_rns_2022-05-25_5b7c282e-58aa-4a6a-9fc4-5a224bca4745.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

ALICE QUEEN LIMITED

ACN 099 247 408

NOTICE OF GENERAL MEETING

TIME : 1.00 p.m (Melbourne time)

DATE : 27 June 2022

PLACE: Moore Australia, Level 44, 600 Bourke Street, Melbourne, Victoria, 3000

This Notice should be read in its entirety. Shareholders in doubt as to how they should vote should seek advice from their professional advisers prior to voting.

Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company Secretary on (+61 3) 8669 1408.

CONTENTS PAGE

Business of the Meeting (setting out the proposed resolutions) 5 Explanatory Statement (explaining the proposed resolutions) 10 Glossary 21 Proxy Form attached

IMPORTANT INFORMATION

TIME AND PLACE OF MEETING

Notice is hereby given that a General Meeting ( Meeting ) of Shareholders of Alice Queen Limited ( Alice Queen or the Company ) will be held at 1.00 p.m. on 27 June 2022 at Moore Australia, Level 44, 600 Bourke Street, Melbourne, Victoria.

The Explanatory Statement that accompanies and forms part of this Notice of General Meeting ( Notice ) sets out the background information on the various matters to be considered. This Notice and Explanatory Statement should be read in their entirety.

YOUR VOTE IS IMPORTANT

The business of the Meeting affects your shareholding and your vote is important.

VOTING ELIGIBILITY

The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 7:00 pm (Melbourne time) on 25 June 2022.

VOTING IN PERSON

To vote in person, attend the Meeting at the time, date and place set out above.

VOTING BY PROXY

To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form.

In accordance with section 249L of the Corporations Act 2001 (Cth) ( Corporations Act ), members are advised that:

  • each member has a right to appoint a proxy;

  • the proxy need not be a member of the Company; and

  • a member who is entitled to cast 2 or more votes may appoint 2 proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the member appoints 2 proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.

2

A proxy may be an individual or a body corporate. If a body corporate is appointed, the proxy form must indicate the full name of the body corporate and the full name and title of the individual representative of the body corporate for the meeting.

A proxy form accompanies this notice. If a shareholder wishes to appoint more than 1 proxy, they may make a copy of the proxy form attached to this notice. For the proxy form to be valid it must be received together with the power of attorney or other authority (if any) under which the form is signed, or a (notarially) certified copy of that power or authority.

Sections 250BB and 250BC of the Corporations Act apply to voting by proxy. Broadly, these provisions provide that:

  • if proxy holders vote, they must cast all directed proxies as directed; and

  • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed.

Further details on these changes are set out below.

Proxy vote if appointment specifies way to vote

Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify the way the proxy is to vote on a particular resolution and, if it does :

  • the proxy need not vote on a poll, but if the proxy does so, the proxy must vote that way (i.e. as directed); and

  • if the proxy has 2 or more appointments that specify different ways to vote on the resolution, the proxy must not vote on a poll; and

  • if the proxy is the chair of the meeting at which the resolution is voted on, the proxy must vote on a poll, and must vote that way (i.e. as directed); and

  • if the proxy is not the chair – the proxy need not vote on the poll, but if the proxy does so, the proxy must vote that way (i.e. as directed).

Transfer of non-chair proxy to chair in certain circumstances

Section 250BC of the Corporations Act provides that, if:

  • an appointment of a proxy specifies the way the proxy is to vote on a particular resolution at a meeting of the Company's members; and

  • the appointed proxy is not the chair of the meeting; and

  • at the meeting, a poll is duly demanded on the resolution; and

  • either of the following applies:

  • the proxy is not recorded as attending the meeting;

  • the proxy does not vote on the resolution,

the chair of the meeting is taken, before voting on the resolution closes, to have been appointed as the proxy for the purposes of voting on the resolution at the meeting.

3

Proxy Voting by the Chair

Subject to any restrictions as set out in the Notice, the Chair intends to vote all available undirected proxies in favour of each item of business.

CORPORATE REPRESENTATIVES

Any corporation which is a member of the Company may appoint a proxy, as set out above, or authorise (by certificate under common seal or other form of execution authorised by the laws of that corporation’s place of incorporation, or in any other manner satisfactory to the Chair) a natural person to act as its representative at any general meeting.

Corporate representatives are requested to bring appropriate evidence of appointment as a representative in accordance with the Constitution. Attorneys are requested to bring an original or certified copy of the power of attorney pursuant to which they were appointed. Proof of identity is also required for corporate representatives and attorneys.

4

BUSINESS OF THE MEETING

AGENDA

RESOLUTION 1: RATIFICATION OF PRIOR ISSUE OF SHARES

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

"That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the prior issue of 162,625,000 fully paid ordinary shares at an issue price of $0.008 (0.8 cents) per share to unrelated professional, sophisticated and other exempt investors identified by 180 Markets Pty Ltd on the terms and conditions set out in the Explanatory Statement which accompanied and formed part of the Notice."

Voting Exclusion: The Company will disregard any votes cast in favour of Resolution 1 by or on behalf of any person who participated in the issue or is a counterparty to the agreement being approved or any associate of that person.

However, the Company need not disregard a vote cast in favour of Resolution 1 by:

  • a person as a proxy or attorney for a person who is entitled to vote on Resolution 1, in accordance with the directions given to the proxy or attorney to vote on Resolution 1 in that way; or

  • the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on Resolution 1, in accordance with a direction given to the Chair to vote on Resolution 1 as the Chair decides; or

  • a holding acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of the beneficiary provided the following conditions are met:

  • the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on Resolution 1; and

  • the holder votes on Resolution 1 in accordance with directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 2A: RATIFICATION OF PRIOR ISSUE OF SHARES

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

"That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the prior issue of 29,644,365 fully paid ordinary shares under ASX Listing Rule 7.1 at an issue price of $0.006 (0.6 cents) per share to unrelated professional, sophisticated and other exempt investors identified by the Company or Evolution Capital Pty Ltd on the terms and conditions set out in the Explanatory Statement which accompanied and formed part of the Notice."

Voting Exclusion: The Company will disregard any votes cast in favour of Resolution 2A by or on behalf of any person who participated in the issue or is a counterparty to the agreement being approved or any associate of that person.

However, the Company need not disregard a vote cast in favour of Resolution 2A by:

5

  • a person as a proxy or attorney for a person who is entitled to vote on Resolution 2A, in accordance with the directions given to the proxy or attorney to vote on Resolution 2A in that way; or

  • the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on Resolution 2A, in accordance with a direction given to the Chair to vote on Resolution 2A as the Chair decides; or

  • a holding acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of the beneficiary provided the following conditions are met:

  • the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on Resolution 2A; and

  • the holder votes on Resolution 2A in accordance with directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 2B: RATIFICATION OF PRIOR ISSUE OF SHARES

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

"That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the prior issue of 137,022,301 fully paid ordinary shares under ASX Listing Rule 7.1A at an issue price of $0.006 (0.6 cents) per share to unrelated professional, sophisticated and other exempt investors identified by the Company or Evolution Capital Pty Ltd on the terms and conditions set out in the Explanatory Statement which accompanied and formed part of the Notice."

Voting Exclusion: The Company will disregard any votes cast in favour of Resolution 2B by or on behalf of any person who participated in the issue or is a counterparty to the agreement being approved or any associate of that person.

However, the Company need not disregard a vote cast in favour of Resolution 2B by:

  • a person as a proxy or attorney for a person who is entitled to vote on Resolution 2B, in accordance with the directions given to the proxy or attorney to vote on Resolution 2B in that way; or

  • the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on Resolution 2B, in accordance with a direction given to the Chair to vote on Resolution 2B as the Chair decides; or

  • a holding acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of the beneficiary provided the following conditions are met:

  • the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on Resolution 2B; and

  • the holder votes on Resolution 2B in accordance with directions given by the beneficiary to the holder to vote in that way.

6

RESOLUTION 3: APPROVAL FOR ISSUE OF PLACEMENT OPTIONS

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

"That for the purposes of ASX Listing Rule 7.1 and all other purposes, approval is given for the Company to issue up to 83,333,500 unlisted options (each with an exercise price of $0.013 (1.3 cents), expiring 3 years from issue and which, upon exercise, entitle the holder to one fully paid ordinary share in the capital of the Company) to investors who participated in the placement of shares the subject of Resolutions 2A and 2B on the terms and conditions set out in the Explanatory Statement which accompanied and formed part of the Notice."

Voting Exclusion: The Company will disregard any votes cast in favour of Resolution 3 by or on behalf of a person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the entity) or any associate of that person.

However, the Company need not disregard a vote cast in favour of Resolution 3 by:

  • a person as a proxy or attorney for a person who is entitled to vote on Resolution 3, in accordance with the directions given to the proxy or attorney to vote on Resolution 3 in that way; or

  • the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on Resolution 3, in accordance with a direction given to the Chair to vote on Resolution 3 as the Chair decides; or

  • a holding acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of the beneficiary provided the following conditions are met:

  • the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on Resolution 3; and

  • the holder votes on Resolution 3 in accordance with directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 4: APPROVAL FOR ISSUE OF SHARES

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

"That for the purposes of ASX Listing Rule 7.1 and all other purposes, approval is given for the Company to issue 88,700,001 fully paid ordinary shares at an issue price of $0.006 (0.6 cents) per share to unrelated professional, sophisticated and other exempt investors identified by the Company or Evolution Capital Pty Ltd on the terms and conditions set out in the Explanatory Statement which accompanied and formed part of the Notice."

Voting Exclusion: The Company will disregard any votes cast in favour of Resolution 4 by or on behalf of a person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the entity) or any associate of that person.

However, the Company need not disregard a vote cast in favour of Resolution 4 by:

7

  • a person as a proxy or attorney for a person who is entitled to vote on Resolution 4, in accordance with the directions given to the proxy or attorney to vote on Resolution 4 in that way; or

  • the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on Resolution 4, in accordance with a direction given to the Chair to vote on Resolution 4 as the Chair decides; or

  • a holding acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of the beneficiary provided the following conditions are met:

  • the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on Resolution 4; and

  • the holder votes on Resolution 4 in accordance with directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 5: APPROVAL FOR ISSUE OF PLACEMENT OPTIONS

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

"That for the purposes of ASX Listing Rule 7.1 and all other purposes, approval is given for the Company to issue up to 44,350,500 unlisted options (each with an exercise price of $0.013 (1.3 cents), expiring 2 years from issue and which, upon exercise, entitle the holder to one fully paid ordinary share in the capital of the Company) to investors who participate in the proposed placement of shares the subject of Resolution 4 on the terms and conditions set out in the Explanatory Statement which accompanied and formed part of the Notice."

Voting Exclusion: The Company will disregard any votes cast in favour of Resolution 5 by or on behalf of a person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the entity) or any associate of that person.

However, the Company need not disregard a vote cast in favour of Resolution 5 by: a person as a proxy or attorney for a person who is entitled to vote on Resolution 5, in accordance with the directions given to the proxy or attorney to vote on Resolution 5 in that way; or

  • the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on Resolution 5, in accordance with a direction given to the Chair to vote on Resolution 5 as the Chair decides; or

  • a holding acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of the beneficiary provided the following conditions are met:

  • the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on Resolution 5; and

  • the holder votes on Resolution 5 in accordance with directions given by the beneficiary to the holder to vote in that way.

8

RESOLUTION 6: APPROVAL FOR ISSUE OF OPTIONS

To consider and, if thought fit, to pass the following Resolution as an ordinary resolution:

“That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue 20,000,000 unlisted options (each with an exercise price of $0.013 (1.3 cents), expiry date 3 years from issue and which, upon exercise, entitle the holder to one fully paid ordinary share in the capital of the Company) to Evolution Capital Pty Ltd (and/or its nominee(s)) as described in the Memorandum which accompanied and formed part of this Notice.”

Voting Exclusion: The Company will disregard any votes cast in favour of Resolution 6 by or on behalf of a person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the entity) or any associate of that person.

However, the Company need not disregard a vote cast in favour of Resolution 6 by:

  • a person as a proxy or attorney for a person who is entitled to vote on Resolution 6, in accordance with the directions given to the proxy or attorney to vote on Resolution 6 in that way; or

  • the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on Resolution 6, in accordance with a direction given to the Chair to vote on Resolution 6 as the Chair decides; or

  • a holding acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of the beneficiary provided the following conditions are met:

  • the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on Resolution 6; and

  • O the holder votes on Resolution 6 in accordance with directions given by the beneficiary to the holder to vote in that way

DATED: 26 MAY 2022 BY ORDER OF THE BOARD ANNE ADALEY COMPANY SECRETARY

9

EXPLANATORY STATEMENT

This Explanatory Statement has been prepared to provide information which the Directors believe to be material to Shareholders deciding whether or not to pass the Resolutions which are the subject of the business of the Meeting.

RESOLUTION 1: RATIFICATION OF PRIOR ISSUE OF SHARES

Resolution 1 seeks shareholder ratification pursuant to ASX Listing Rule 7.4 for the prior issue of 162,625,000 fully paid ordinary shares in the capital of the Company ( Q1 Placement Shares ) at an issue price of $0.008 (0.8 cents) per Q1 Placement Share to professional, sophisticated and other investors exempt from the disclosure requirements of Chapter 6D of the Corporations Act identified by 180 Markets Pty Ltd as lead manager of the Placement, raising $1,301,000 before costs of the Placement.

The Q1 Placement Shares were issued on 28 January 2022 and an Appendix 2A was released to ASX on 31 January 2022.

The Q1 Placement Shares were issued without shareholder approval under ASX Listing Rule 7.1. ASX Listing Rule 7.1 provides that a company must not, subject to specified exceptions, issue or agree to issue during any twelve (12) month period any equity securities, or other securities with rights to conversion to equity, if the number of those securities exceeds 15% of the share capital of the Company at the commencement of that twelve (12) month period.

ASX Listing Rule 7.4 provides that where a company’s shareholders ratify the prior issue of securities, or an agreement to issue securities, made pursuant to ASX Listing Rule 7.1 (provided the previous issue of securities did not breach ASX Listing Rule 7.1) those securities will be deemed to have been issued or agreed to be issued with shareholder approval for the purposes of ASX Listing Rule 7.1. The Company seeks approval under Listing Rule 7.4 to refresh its capacity to make further issues without shareholder approval under Listing Rule 7.1.

Accordingly, Resolution 1 seeks Shareholder approval under ASX Listing Rule 7.4 for and ratification of the issue of the Q1 Placement Shares issued under the Company’s 15% placement capacity under ASX Listing Rule 7.1 to provide flexibility for the Company to issue securities under the Company's 15% placement capacity in the next 12 months without the requirement to obtain Shareholder approval.

If shareholders pass Resolution 1, the Q1 Placement Shares will be treated as not having used placement capacity of the Company under the ASX Listing Rules and the Company will be able to issue equity securities using the refreshed placement capacity without shareholder approval. If shareholders do not pass Resolution 1 the Q1 Placement Shares will continue to use the placement capacity that is available to the Company under the ASX Listing Rules.

The following information is provided in accordance with the requirements of ASX Listing Rule 7.5:

The number of
Shares issued:
A total of 162,625,000 fully paid ordinary shares (Q1 Placement
Shares) were issued under the Company’s 15% placement
capacity under ASX Listing Rule 7.1.
Issue date: The Q1 Placement Shares were issued on 28 January 2022 and an
Appendix 2A was released to ASX on 31 January 2022.

10

Issue price: $0.008 per Q1 Placement Share.
Terms of securities: The Q1 Placement Shares issued were all fully paid ordinary shares
in the capital of the Company issued on the same terms and
conditions as the Company's existing shares.
Person to whom
Shares were
issued:
The Q1 Placement Shares were issued to unrelated sophisticated,
professional and other exempt investors who were identified by 180
Markets Pty Ltd.
Use of funds: $1,301,000 before costs was raised from the issue of the Q1
Placement Shares. The funds raised have been, or proposed to
be, applied towards:
• Exploration drilling program at Horn Island; and
• general working capital.
Voting exclusion: A voting exclusion for Resolution 1 is contained in the Notice.

Recommendation

The Directors recommend Shareholders vote in favour of this Resolution 1.

BACKGROUND TO RESOLUTIONS 2, 3, 4,5 AND 6

On 28 April 2022, the Company announced that it had obtained binding commitments for the issue of up to approximately 255,366,667 fully paid ordinary shares ( Q2 Placement Shares ) at an issue price of $0.006 (0.6 cents) per Q2 Placement Share to raise $1.5 million before costs ( Q2 Placement ).

As noted in that announcement, the issue of the Q2 Placement shares will be completed in two tranches of which:

  • 166,666,666 Q2 Placement Shares ( Tranche 1 Placement Shares ) were issued on 6 May 2022 without shareholder approval, with 29,644,365 Tranche 1 Placement Shares being issued under the Company’s placement capacity under LR7.1 and 137,022,301 Tranche 1 Placement Shares being issued under the Company’s placement capacity under LR7.1A. The Tranche 1 Placement Shares were issued on 6 May 2022 and an Appendix 2A for the issue of the was released to ASX on the date: and

  • 88,700,001 Q2 Placement Shares ( Tranche 2 Placement Shares ) are to be issued, subject to shareholder approval at the next general meeting of the Company, such shareholder approval being sought under Resolution 4.

The Q2 Placement is also proposed to include one attaching option ( Placement Option ) for every two Q2 Placement Shares issued, with each Placement Option having an exercise price of A$0.013, expiry date of 3 years from the date of issue and which, upon exercise, entitle the holder to one fully paid ordinary share in the capital of the Company. The full terms of the Placement Options are set out in Annexure 1. The issue of the Placement Options is subject to receipt of shareholder approval. The Company proposes seeking quotation of the Placement Options if Resolutions 3 and 5 are approved. The quotation of the Placement Options is also subject to the Company meeting the requirements for quotation under applicable law (including the ASX Listing Rules) and the issue of a prospectus.

11

The participants in the Q2 Placement are unrelated sophisticated, professional and other exempt investors who were identified by the Company or by Evolution Capital Pty Ltd ( Evolution Capital ) who acted as lead manager of the Q2 Placement. Evolution Capital is to receive a commission fee equal to 5% plus GST of the total funds raised from the Q2 Placement. Furthermore, Evolution Capital will receive 20,000,000 options ( Broker Options ) with the same terms and conditions as the Placement Options, subject to Resolution 6 being approved by Shareholders at this meeting. The Company proposes seeking quotation of the Broker Options at the same time as seeking quotation of the Placement Options, on the same terms and conditions as described above.

RESOLUTIONS 2A AND 2B – ASX LISTING RULES

Resolutions 2A and 2B seek shareholder ratification of the prior issue of an aggregate of 166,666,666 Tranche 1 Placement Shares to sophisticated, professional and other exempt investors who were identified by the Company or Evolution Capital. The Tranche 1 Placement Shares were issued on 6 May 2022 and an Appendix 2A was released to ASX on that date. The Tranche1 Placement Shares the subject of Resolutions 2A and 2B were issued without shareholder approval under ASX Listing Rules 7.1 and 7.1A. 29,644,365 Tranche 1 Placement Shares were issued under Listing Rule 7.1 (being the subject of Resolution 2A) and 137,022,301 Tranche 1 Placement Shares were issued under Listing Rule 7.1A (being the subject of Resolution 2B).

ASX Listing Rule 7.1, subject to ASX Listing Rule 7.1A (among others) provides that a company must not, subject to specified exceptions, issue or agree to issue during any twelve (12) month period any equity securities, or other securities with rights to conversion to equity, if the number of those securities exceeds 15% of the share capital of the Company at the commencement of that twelve (12) month period.

The Company obtained shareholder approval under ASX Listing Rule 7.1A to issue shares under an additional 10% placement capacity at its 2021 AGM on 25 November 2021.

ASX Listing Rule 7.4 provides that where a company’s shareholders ratify the prior issue of securities made pursuant to ASX Listing Rule 7.1 and/or 7.1A (provided that the previous issue of securities did not breach ASX Listing Rule 7.1 and/or 7.1A) those securities will be deemed to have been issued with shareholder approval for the purposes of ASX Listing Rule 7.1 and/or 7.1A. The Company seeks approval under Listing Rule 7.4 to refresh its capacity to make further issues without shareholder approval under Listing Rule 7.1 and/or 7.1A.

Accordingly, Resolutions 2A and 2B in aggregate seek Shareholder approval under ASX Listing Rule 7.4 for and ratification of the issue of all of the Tranche 1 Placement Shares issued under the Company’s 15% placement capacity under ASX Listing Rule 7.1 and 10% placement capacity under ASX Listing Rule 7.1A to provide flexibility for the Company to issue securities under the Company's aggregate 25% placement capacity in the next 12 months without the requirement to obtain Shareholder approval.

If shareholders:

  • (a) pass Resolutions 2A and 2B, all of the issued Tranche 1 Placement Shares the subject of Resolutions 2A and 2B will be treated as not having used placement capacity of the Company under the ASX Listing Rules and the Company will be able to issue equity securities using the refreshed placement capacity without shareholder approval.

  • (b) Approve only one of Resolutions 2A or 2B, then only the issued Tranche 1 Placement Shares the subject of the resolution passed by shareholders will be treated as not having used placement capacity of the Company under the ASX Listing Rules and the Company will be able to issue equity securities using the refreshed placement capacity without shareholder approval in respect of those Tranche 1 Placement Shares the subject of the resolution passed by shareholders. The Tranche 1 Placement

12

Shares the subject of the resolution that is not passed by shareholder would continue to use the placement capacity that is available to the Company under the ASX Listing Rules.

  • (c) If shareholders do not pass both Resolutions 2A and 2B then all of the Tranche 1 Placement Shares will continue to use placement capacity that is available to the Company under the ASX Listing Rules.

2.1 Information required by ASX Listing Rule 7.5 – Resolution 2A

Pursuant to and in accordance with ASX Listing Rule 7.5, the following information is provided in relation to Resolution 2A:

The number of
Shares issued:
A total of 29,644,365 fully paid ordinary shares (Tranche 1
Placement Shares were issued under the Company’s 15%
placement capacity under ASX Listing Rule 7.1.
Issue date: The Tranche 1 Placement Shares the subject of Resolution 2A were
issued on 6 May 2022 and an Appendix 2A was released to ASX
on that date.
Issue price: $0.006 per Tranche 1 Placement Share.
Terms of securities: The Tranche 1 Placement Shares the subject of Resolution 2A were
all fully paid ordinary shares in the capital of the Company issued
on the same terms and conditions as the Company’s existing
shares.
Person to whom
Shares were
issued:
The Tranche 1 Placement Shares the subject of Resolution 2A were
issued to unrelated sophisticated, professional and other exempt
investors who were identified by the Company or Evolution
Capital.
Use of funds: $177,866.19 before costs was raised from the issue of Tranche 1
Placement Shares. The funds raised have been, or are proposed
to be, used for:
• exploration Drilling at Horn Island.
• progressing
advanced
discussions
for
joint
venture
opportunities on NSW projects to accelerate further drilling;
and
• general working capital including costs of the Q2 Placement.
Voting exclusion: A voting exclusion for Resolution 2A is contained in the Notice.

2.2 Recommendation – Resolution 2A

The Directors recommend Shareholders vote in favour of this Resolution 2A.

2.3 Information required by ASX Listing Rule 7.5 – Resolution 2B

Pursuant to and in accordance with ASX Listing Rule 7.5, the following information is provided in relation to Resolution 2B:

13

The number of
Shares issued:
A total of 137,022,301 fully paid ordinary shares (Tranche 1
Placement Shares were issued under the Company’s 10%
placement capacity under ASX Listing Rule 7.1A.
Issue date: The Tranche 1 Placement Shares the subject of Resolution 2B were
issued on 6 May 2022 and an Appendix 2A was released to ASX
on that date.
Issue price: $0.006 per Tranche 1 Placement Share.
Terms of securities: The Tranche 1 Placement Shares the subject of Resolution 2B were
all fully paid ordinary shares in the capital of the Company issued
on the same terms and conditions as the Company’s existing
shares.
Person to whom
Shares were
issued:
The Tranche 1 Placement Shares the subject of Resolution 2B were
issued to unrelated sophisticated, professional and other exempt
investors who were identified by the Company or Evolution
Capital.
Use of funds: $822,133.81 before costs was raised from the issue of Tranche 1
Placement Shares the subject of Resolution 2B. The funds raised
have been, or are proposed to be, used for:
• exploration Drilling at Horn Island.
• progressing
advanced
discussions
for
joint
venture
opportunities on NSW projects to accelerate further drilling;
and
• general working capital including costs of the Q2 Placement.
Voting exclusion: A voting exclusion for Resolution 2B is contained in the Notice.

2.4 Recommendation – Resolution 2B

The Directors recommend Shareholders vote in favour of this Resolution 2B.

RESOLUTION 3 – ASX LISTING RULES

Resolution 3 seeks shareholder approval for the purposes of ASX Listing Rule 7.1 and for all other purposes for the Company to issue up to 83,333,500 Placement Options (each having an exercise price of A$0.013, expiry date of 3 years from the date of issue and which, upon exercise, entitle the holder to one fully paid ordinary share in the capital of the Company). The full terms of the Placement Options are set out in Annexure 1.

The Placement Options are to be issued as free-attaching to the Tranche 1 Placement Shares the subject of Resolutions 2A and 2B on the basis of one Placement Option for every two Tranche 1 Placement Shares issued. Further details of the Tranche 1 Placement Shares, including details of the recipients of the Tranche 1 Placement Shares, are set out in Resolution 2A and 2B. The issue of the Tranche 1 Placement Options is subject to shareholder approval and the Company proposes seeking quotation of the Placement Options on ASX if Resolution 3 is approved. The quotation of the Placement Options is subject to the Company meeting the requirements for quotation under applicable law (including the ASX Listing Rules) and the issue of a prospectus.

14

The Company is seeking shareholder approval under Resolution 3 to issue up to a number of Placement Options that is more than half of the number of Tranche 1 Placement Shares issued in order to accommodate any fractional entitlements to Placement Options that are rounded up.

Listing Rule 7.1 provides that a company must not, subject to specific exceptions, issue or agree to issue during any twelve-month period any equity securities, or other securities with rights to conversion to equity, if the number of those securities exceeds 15% of the company’s issued share capital at the commencement of the twelve month period. One circumstance where an action or an issue is not taken into account in calculating the 15% threshold is where the issue has the prior approval of shareholders at a general meeting.

If shareholders approve Resolution 3, the Company will be able to issue up to the number of Placement Options for which approval is sought under Resolution 3 on the basis of one Placement Option for every two Tranche 1 Placement Shares issued. If any of the Placement Options the subject of Resolution 3 are exercised into ordinary shares, the placement capacity of the Company to issue equity securities under Listing Rule 7.1 and, subject to the relevant shareholder approval being held at the time, Listing Rule 7.1A, will be increased. If shareholders do not approve Resolution 3 then the Company will not be able to issue the Placement Options the subject of Resolution 3.

3.1 Required information

ASX Listing Rule 7.3 requires that the following information be provided to Shareholders in respect of Resolution 3 for the purposes of providing an approval under Listing Rule 7.1.

Maximum number of
Securities to be issued:
Up to 83,333,500 Placement Options, which are to be issued
on the basis of one Placement Option for every two Tranche
1 Placement Shares issued.
Recipients: Participants in the Q2 Placement, on the basis of one
Placement Option for every two Tranche 1 Placement
Shares subscribed for under the Q2 Placement. The
recipients of the Tranche 1 Placement Shares comprised
unrelated sophisticated, professional and other exempt
investors who were identified by the Company or Evolution
Capital.
Proposed date of Issue: All of the Placement Options the subject of Resolution 3 will
be issued no later than three months after the date of the
Meeting (or such later date to the extent permitted by any
ASX waiver or modification of the ASX Listing Rules).
Price at which the
Placement Options are
to be issued:
Nil issue price, Placement Options are being issued as free-
attaching on the basis of one Placement Option for every
two Tranche 1 Placement Shares issued.
Terms of securities: Placement Options each have an exercise price of
A$0.013, expiry date of 3 years from the date of issue and
which, upon exercise, entitle the holder to one fully paid
ordinary share in the capital of the Company. The full terms
of the Placement Options are set out in in Annexure 1.
Use of funds: No funds will be raised by the issue of the Placement
Options, which are being issued as free-attaching on the
basis ofonePlacementOption foreverytwoTranche1

15

Placement Shares issued. Funds raised on exercise of
Placement Options (if any) will be applied to meeting the
working capital requirements of the Company at the time
of exercise.
Voting exclusion: A voting exclusion for Resolution 3 is contained in the
Notice.

3.2 Recommendation

The Directors recommend Shareholders vote in favour of this Resolution 3.

RESOLUTION 4 – ASX LISTING RULES

Resolution 4 seeks shareholder approval for the purposes of ASX Listing Rule 7.1 and for all other purposes for the Company to issue up to 88,700,001 Tranche 2 Placement Shares to sophisticated, professional and other exempt investors who were identified by the Company or Evolution Capital (who acted as lead manager of the Q2 Placement).

The Company is seeking shareholder approval to issue the Tranche 2 Placement Shares in order to preserve its placement capacity under ASX Listing Rule 7.1. An Appendix 3B for the issue of the Tranche 2 Placement Shares was released to ASX on 28 April 2022.

Listing Rule 7.1 provides that a company must not, subject to specific exceptions, issue or agree to issue during any twelve-month period any equity securities, or other securities with rights to conversion to equity, if the number of those securities exceeds 15% of the company’s issued share capital at the commencement of the twelve month period. One circumstance where an action or an issue is not taken into account in calculating the 15% threshold is where the issue has the prior approval of shareholders at a general meeting.

If shareholders approve Resolution 4, the Company will be able to issue the Tranche 2 Placement Shares without using the placement capacity available to the Company under the ASX Listing Rules. If shareholders do not approve Resolution 4, then the Company will not be able to issue the Tranche 2 Placement Shares the subject of Resolution 4.

4.1 Required information

ASX Listing Rule 7.3 requires that the following information be provided to Shareholders in respect of Resolution 4 for the purposes of providing an approval under Listing Rule 7.1.

Maximum number of
Securities to be issued:
A total of up to 88,700,001 fully paid ordinary shares
(Tranche 2 Placement Shares).
Recipients: The Tranche 2 Placement Shares are to be issued to
unrelated sophisticated, professional and other exempt
investors who were identified by the Company or Evolution
Capital.
Proposed date of Issue: Tranche 2 Placement Shares will be issued no later than
three months after the date of the Meeting (or such later
date to the extent permitted by any ASX waiver or
modification of the ASX Listing Rules.
Issue Price: $0.006 per Tranche 2 Placement Share.
Terms of securities: The Tranche 2 Placement Shares when issued, will be fully
paid ordinary shares in the capital of the Company and

16

issued on the same terms and conditions as the Company's
existing shares.
Use of funds: $532,200.01 before costs will be raised from the issue of
Tranche 2 Placement Shares. The funds raised will be used
for:
• exploration Drilling at Horn Island.
• progressing advanced discussions for joint venture
opportunities on NSW projects to accelerate further
drilling; and
• general working capital including costs of the Q2
Placement.
Voting exclusion: A voting exclusion for Resolution 4 is contained in the
Notice.

4.2 Recommendation

The Directors recommend Shareholders vote in favour of this Resolution 4.

RESOLUTION 5 – ASX LISTING RULES

Resolution 5 seeks shareholder approval for the purposes of ASX Listing Rule 7.1 and for all other purposes for the Company to issue up to 44,350,500 Placement Options (each having an exercise price of A$0.013, expiry date of 3 years from the date of issue and which, upon exercise, entitle the holder to one fully paid ordinary share in the capital of the Company). The full terms of the Placement Options are set out in Annexure 1.

The Placement Options are to be issued as free-attaching to Tranche 2 Placement Shares the subject of Resolution 4 on the basis of one Placement Option for every two Tranche 2 Placement Shares issued. Further details of the Tranche 2 Placement Shares, including details of the proposed recipients of the Tranche 2 Placement Shares, are set out in the explanatory text for Resolution 4. The issue of the Tranche 2 Placement Options is subject to shareholder approval and the Company proposes seeking quotation of the Placement Options on ASX if Resolution 5 is approved. The quotation of the Placement Options is subject to the Company meeting the requirements for quotation under applicable law (including the ASX Listing Rules) and the issue of a prospectus.

The Company is seeking shareholder approval under Resolution 5 to issue up to a number of Placement Options that is more than half of the number of Tranche 2 Placement Shares issued in order to accommodate any fractional entitlements to Placement Options that are rounded up.

Listing Rule 7.1 provides that a company must not, subject to specific exceptions, issue or agree to issue during any twelve-month period any equity securities, or other securities with rights to conversion to equity, if the number of those securities exceeds 15% of the company’s issued share capital at the commencement of the twelve-month period. One circumstance where an action or an issue is not taken into account in calculating the 15% threshold is where the issue has the prior approval of shareholders at a general meeting.

If shareholders approve Resolution 5, the Company will be able to issue up to the number of Placement Options for which approval is sought under Resolution 5 on the basis of one

17

Placement Option for every two Tranche 2 Placement Shares issued. If any of the Placement Options the subject of Resolution 5 are exercised into ordinary shares, the placement capacity of the Company to issue equity securities under Listing Rule 7.1 and, subject to the relevant shareholder approval being held at the time, Listing Rule 7.1A, will be increased. If shareholders do not approve Resolution 5 then the Company will not be able to issue the Placement Options the subject of Resolution 5.

5.1 Required information

ASX Listing Rule 7.3 requires that the following information be provided to Shareholders in respect of Resolution 5 for the purposes of providing an approval under Listing Rule 7.1.

Maximum number of
Securities to be issued:
Up to 44,350,500 Placement Options, which are to be issued
on the basis of one Placement Option for every two Tranche
2 Placement Shares issued.
Recipients: Participants in the Q2 Placement, on the basis of one
Placement Option for every two Tranche 2 Placement
Shares subscribed for under the Q2 Placement. The
recipients of the Tranche 2 Placement Shares will be
comprised of unrelated sophisticated, professional and
other exempt investors who were identified by the
Company Evolution Capital.
Proposed date of Issue: All of the Placement Options the subject of Resolution 5 will
be issued no later than three months after the date of the
Meeting (or such later date to the extent permitted by any
ASX waiver or modification of the ASX Listing Rules).
Price at which the
Placement Options are
to be issued:
Nil issue price, Placement Options are being issued as free-
attaching on the basis of one Placement Option for every
two Tranche 2 Placement Shares issued.
Terms of securities: Placement Options each have an exercise price of
A$0.013, expiry date of 3 years from the date of issue and
which, upon exercise, entitle the holder to one fully paid
ordinary share in the capital of the Company. The full terms
of the Placement Options are set out in in Annexure 1.
Use of funds: No funds will be raised by the issue of the Placement
Options, which are being issued as free-attaching on the
basis of one Placement Option for every two Tranche 2
Placement Shares issued. Funds raised on exercise of
Placement Options (if any) will be applied to meeting the
working capital requirements of the Company at the time
of exercise.
Voting exclusion: A voting exclusion for Resolution 5 is contained in the
Notice.

5.2 Recommendation

The Directors recommend Shareholders vote in favour of this Resolution 5.

18

RESOLUTION 6 – APPROVAL FOR ISSUE OF OPTIONS

Resolutions 6 seek shareholder approval for the purposes of ASX Listing Rule 7.1 and for all other purposes to issue 20,000,000 options ( Broker Options ) to Evolution Capital (and/or its nominee(s)) in connection with the role of Evolution Capital as lead manager of the Q2 Placement conducted by the Company the subject of Resolutions 2, 3, 4 and 5.

Each Broker Option the subject of Resolution 6 have the same terms as the Placement Options, being an exercise price of $0.013, expiry date of 3 years from issue and, upon exercise, entitle the holder to one fully paid ordinary share in the capital of the Company. Broker Options otherwise have the terms set out in Annexure A.

The issue of Broker Options to Evolution Capital (and/or its nominee(s)) is subject to shareholder approval. The Company proposes seeking quotation of these Broker Options (which have the same terms as the Placement Options) on the ASX if Resolution 6 is approved. The quotation of the Placement Options and the Broker Options is subject to the Company meeting the requirements for quotation under applicable law (including the ASX Listing Rules) and the issue of a prospectus.

ASX LISTING RULES

ASX Listing Rule 7.1 provides that a company must not, subject to specific exceptions, issue or agree to issue during any twelve-month period any equity securities, or other securities with rights to conversion to equity, if the number of those securities exceeds 15% of the company’s issued share capital at the commencement of the twelve-month period. One circumstance where an action or an issue is not taken into account in calculating the 15% threshold is where the issue has the prior approval of shareholders at a general meeting.

If shareholders approve Resolution 6, the Company will be able to issue 20,000,000 Broker Options to Evolution Capital (and/or its nominee(s)). In addition, if any of the Broker Options are exercised into ordinary shares, the Company’s capacity to issue equity securities under the ASX Listing Rules will be increased. If shareholders do not approve Resolutions 6, the Company will not be able to issue the Broker Options to Evolution Capital (and/or its nominee(s)).

7.1 Required information

The following information is provided in accordance with the requirements of ASX Listing Rule 7.3 in respect of Resolution 6:

Maximum number of
Securities to be issued:
20,000,000 Broker Options
Recipients: Evolution Capital Pty Ltd (and/or its nominee(s)). Evolution
Capital is not a related party of the Company.
Proposed date of Issue: The Broker Options the subject of Resolution 6 will be issued
no later than three months after the date of the Meeting (or
such later date to the extent permitted by any ASX waiver
or modification of the ASX Listing Rules).
Price at which the
Broker Options are to
be issued:
Nil issue price. Broker Options are to be issued to Evolution
Pty Ltd (and/or its nominee(s)) in connection with their role
as lead manager of the Q2 Placement conducted by the
Company the subject of Resolutions 2, 3, 4 and 5.

19

Terms of securities: Broker Options each have an exercise price of A$0.013,
expiry date of 3 years from the date of issue and which,
upon exercise, entitle the holder to one fully paid ordinary
share in the capital of the Company. The full terms of the
Broker Options are set out in in Annexure 1.
Use of funds: No funds will be raised by the issue of the Broker Options,
which are being issued as part of the fee due to Evolution
Capital for acting as lead manager of the Q2 Placement
conducted by the Company the subject of Resolutions 2, 3,
4 and 5. Funds raised on exercise of the Broker Options (if
any) will be applied to meeting the working capital
requirements of the Company at the time of exercise.
Material terms of the
Agreement:
The Broker Options the subject of Resolution 6 are being
issued to Evolution Capital and/or its nominee(s) pursuant
to the terms of an engagement letter between the
Company and Evolution Capital (Letter).
The material terms of the Letter are summarised below:

Evolution Capital agreed to act as lead manager of
the placement of the Q2 Placement Shares and free-
attaching
Placement
Options
the
subject
of
Resolutions 2, 3, 4 and 5.

Subject to Evolution Capital confirming that it has
received irrevocable binding commitments to the Q2
Placement for not less than $600,000, for its role as
lead manager, the Company agreed to pay
Evolution Capital (and/or its nominee(s)) fees
comprising:
o
20,000,000 Broker Options, subject to shareholder
approval (being the Broker Options the subject of
Resolution 6); and
o
fee equal to 5% of the funds raised under the Q2
Placement plus GST.
Voting exclusion: A voting exclusion for Resolution 6 is contained in the
Notice.

6.2 Recommendation

The Directors recommend Shareholders vote in favour of this Resolution 6.

Note: references in the Notice and the Memorandum to “$” are to Australian currency.

20

GLOSSARY (WHE RE NOT OTHERWISE DEFI NED)

$ means Australian dollars.

General Meeting or Meeting means the meeting convened by the Notice.

ASX means ASX Limited.

ASX Listing Rules means the Listing Rules of ASX.

Board means the current board of directors of the Company.

Business Day means Monday to Friday inclusive, except New Year's Day, Good Friday, Easter Monday, Christmas Day, Boxing Day, and any other day that ASX declares is not a business day.

Chair means the chair of the Meeting.

Company means Alice Queen Limited (ACN 099 247 408).

Constitution means the Company’s constitution.

Corporations Act means the Corporations Act 2001 (Cth).

Directors means the current directors of the Company.

Explanatory Statement means the explanatory statement accompanying the Notice.

Notice means this notice of meeting including the Explanatory Statement and Proxy Form.

Option Holder means a holder of an Option.

Proxy Form means the proxy form accompanying the Notice.

Resolutions means the resolutions set out in the Notice, or any one of them, as the context requires.

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a holder of a Share.

VWAP means volume weighted average price.

21

ANNEXURE 1: TERMS OF OPTIONS

Note: a reference to “Option” or “Options” in this Annexure 1 are to Placement Options and the Broker Options the subject of Resolution 6 collectively.

  • Each option ( Option ) entitles the holder to acquire one ordinary fully paid share ( Share ) in the capital of the Company. All options will be unlisted.

  • The exercise price is 1.3 cents ($0.013) per option.

  • Each Option is exercisable at any time prior to 5.00pm Melbourne time on the date which is 3 years from the issue date ( Expiry Date ) by providing written notice together with payment for the number of Shares in respect of which Options are exercised to the registered office of the Company.

  • Any Option that has not been exercised prior to the expiry date automatically lapses.

  • Holders shall not be entitled to exercise their Options (and the Company will not be required to issue shares upon such exercise) if it would be unlawful to do so.

  • The exercise price is payable in full on exercise.

  • Where an Option holder determines to exercise some, but not all, of their held Options, the total aggregate amount payable to exercise the Options must be a minimum of $1,000.

  • Subject to compliance with applicable law, the Options are freely transferable.

  • All Shares issued upon exercise of Options will rank pari passu in all respects with, and will have the same terms as, the Company's then issued ordinary fully paid shares. Whilst admitted to the Official List of the ASX, the Company will apply for official quotation by ASX of all Shares issued upon exercise of Options, subject to any restriction obligations imposed by ASX. The Options will not give any right to participate in dividends until shares are issued pursuant to the exercise of the relevant Options.

  • There are no participation rights or entitlements inherent in the Options. Option holders are not entitled to participate in new issues of securities offered to shareholders without first exercising the Option. The Company will send notices to option holders at least five (5) business days prior to the record date (or such shorter period as allowed by the ASX Listing Rules) applying to offers of securities made to shareholders during the currency of the Options.

  • In the event of any reconstruction (including consolidation, subdivision, reduction or return) of the issued capital of the Company prior to the expiry date, the number of Options or the exercise price of the options or both shall be reconstructed in accordance with the ASX Listing Rules applying to a reorganisation of capital at the time of the reconstruction.

  • Whilst the Company is admitted to the Official List of ASX, these terms of Options will be varied as required to comply with the requirements of ASX.

22

==> picture [136 x 63] intentionally omitted <==

==> picture [11 x 13] intentionally omitted <==

==> picture [11 x 13] intentionally omitted <==

==> picture [14 x 13] intentionally omitted <==

==> picture [14 x 13] intentionally omitted <==

Need assistance?

Phone:

1300 850 505 (within Australia) +61 3 9415 4000 (outside Australia)

Online:

www.investorcentre.com/contact

AQX

MR SAM SAMPLE FLAT 123 123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030

YOUR VOTE IS IMPORTANT

For your proxy appointment to be effective it must be received by 1:00pm (AEST) on Saturday, 25 June 2022.

Proxy Form

How to Vote on Items of Business

Lodge your Proxy Form:

XX

All your securities will be voted in accordance with your directions.

Online:

APPOINTMENT OF PROXY

Voting 100% of your holding: Direct your proxy how to vote by marking one of the boxes opposite each item of business. If you do not mark a box your proxy may vote or abstain as they choose (to the extent permitted by law). If you mark more than one box on an item your vote will be invalid on that item.

Voting a portion of your holding: Indicate a portion of your voting rights by inserting the percentage or number of securities you wish to vote in the For, Against or Abstain box or boxes. The sum of the votes cast must not exceed your voting entitlement or 100%.

Appointing a second proxy: You are entitled to appoint up to two proxies to attend the meeting and vote on a poll. If you appoint two proxies you must specify the percentage of votes or number of securities for each proxy, otherwise each proxy may exercise half of the votes. When appointing a second proxy write both names and the percentage of votes or number of securities for each in Step 1 overleaf.

Lodge your vote online at www.investorvote.com.au using your secure access information or use your mobile device to scan the personalised QR code.

Your secure access information is

==> picture [47 x 49] intentionally omitted <==

Control Number: 999999

SRN/HIN: I9999999999 PIN: 99999

For Intermediary Online subscribers (custodians) go to www.intermediaryonline.com

A proxy need not be a securityholder of the Company.

SIGNING INSTRUCTIONS FOR POSTAL FORMS

Individual: Where the holding is in one name, the securityholder must sign.

Joint Holding: Where the holding is in more than one name, all of the securityholders should sign.

Power of Attorney: If you have not already lodged the Power of Attorney with the registry, please attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: Where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please sign in the appropriate place to indicate the office held. Delete titles as applicable.

By Mail:

Computershare Investor Services Pty Limited GPO Box 242 Melbourne VIC 3001 Australia

By Fax:

1800 783 447 within Australia or +61 3 9473 2555 outside Australia

PARTICIPATING IN THE MEETING

Corporate Representative

If a representative of a corporate securityholder or proxy is to participate in the meeting you will need to provide the appropriate “Appointment of Corporate Representative”. A form may be obtained from Computershare or online at www.investorcentre.com/au and select "Printable Forms".

PLEASE NOTE: For security reasons it is important that you keep your SRN/HIN confidential.

Samples/000001/000002/i12

MR SAM SAMPLE FLAT 123 123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030

Change of address. If incorrect, mark this box and make the correction in the space to the left. Securityholders sponsored by a broker (reference number commences with ‘ X ’) should advise your broker of any changes.



I 9999999999

I ND

Proxy Form

Step 1

Appoint a Proxy to Vote on Your Behalf

Please mark to indicate your directions

XX

I/We being a member/s of Alice Queen Limited hereby appoint

the Chairman OR of the Meeting

PLEASE NOTE: Leave this box blank if you have selected the Chairman of the Meeting. Do not insert your own name(s).

or failing the individual or body corporate named, or if no individual or body corporate is named, the Chairman of the Meeting, as my/our proxy to act generally at the meeting on my/our behalf and to vote in accordance with the following directions (or if no directions have been given, and to the extent permitted by law, as the proxy sees fit) at the General Meeting of Alice Queen Limited to be held at Moore Australia, Level 44, 600 Bourke Street, Melbourne, Victoria 3000 on Monday, 27 June 2022 at 1:00pm (AEST) and at any adjournment or postponement of that meeting.

Step 2 Items of Business

PLEASE NOTE: If you mark the Abstain box for an item, you are directing your proxy not to vote on your behalf on a show of hands or a poll and your votes will not be counted in computing the required majority.

For Against Abstain

Resolution 1 Ratification of Prior Issue of 162,625,000 Shares
Resolution 2A Ratification of Prior Issue of 29,644,365 Shares
Resolution 2B Ratification of Prior Issue of 137,022,301 Shares
Resolution 3 Approval for Issue of 83,333,500 Placement Options
Resolution 4 Approval for Issue of 88,700,001 Shares
Resolution 5 Approval for Issue of 44,350,001 Placement Options
Resolution 6 Approval for Issue of Options to Evolution Capital Pty Ltd

The Chairman of the Meeting intends to vote undirected proxies in favour of each item of business. In exceptional circumstances, the Chairman of the Meeting may change his/her voting intention on any resolution, in which case an ASX announcement will be made.

Step 3 Signature of Securityholder(s)

This section must be completed.

==> picture [514 x 69] intentionally omitted <==

----- Start of picture text -----

Individual or Securityholder 1 Securityholder 2 Securityholder 3
/ /
Sole Director & Sole Company Secretary Director Director/Company Secretary Date
Update your communication details (Optional) By providing your email address, you consent to receive future Notice
Mobile Number Email Address of Meeting & Proxy communications electronically
----- End of picture text -----

A Q X

2 8 8 2 7 7 A